Literature DB >> 6201183

An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes.

K W Walton, T J Almond, M Robinson, D L Scott.   

Abstract

An experimental model is described which provides direct evidence of endocytosis of complexes of a charged colloid (dextran sulphate or DS) and of plasma fibronectin (FN) by reticulo-endothelial (RE) cells. This supports previous suggestions that plasma FN acts as a non-immunologically mediated opsonin which effects the clearance of various kinds of circulating colloids and particles by RE cells. DS of molecular weight 500 000 forms FN-containing complexes in rat plasma in vitro and lowers plasma FN levels acutely and in a dose-related fashion when given parenterally to rats. The plasma changes are accompanied by deposition of DS (shown histochemically as metachromatic material) and of FN (shown by specific immunofluorescence) in an identical distribution within RE cells in rat liver and spleen. The protein and polysaccharide components of the complex are disposed of by RE cells at markedly different rates. The model thus also offers a means of studying the dynamics of catabolism of plasma FN by this 'scavenger' pathway. Possible further extensions of the model for other purposes are also discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201183      PMCID: PMC2040966     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  13 in total

1.  Purification of opsonically active human and rat cold-insoluble globulin (plasma fibronectin).

Authors:  J Molnar; F B Gelder; M Z Lai; G E Siefring; R B Credo; L Lorand
Journal:  Biochemistry       Date:  1979-09-04       Impact factor: 3.162

2.  Investigation of the histochemical basis of metachromasia.

Authors:  K W WALTON; C R RICKETTS
Journal:  Br J Exp Pathol       Date:  1954-06

3.  Observations on the effects, of a series of dextran sulphates of varying molecular weight on the formed elements of the blood in vitro.

Authors:  K W WALTON
Journal:  Br J Pharmacol Chemother       Date:  1953-09

4.  Purification of alpha-2-opsonic protein from human serum and its measurement by immunoassay.

Authors:  F A Blumenstock; T M Saba; P Weber
Journal:  J Reticuloendothel Soc       Date:  1978-02

5.  Functional hyposplenism during pneumococcal infection.

Authors:  B J Boughton; A Simpson; S Chandler
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

6.  Plasma fibronectin in acute leukaemia.

Authors:  B J Boughton; A Simpson
Journal:  Br J Haematol       Date:  1982-07       Impact factor: 6.998

7.  Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function.

Authors:  T M Saba; E Jaffe
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

8.  Localization of antigen in tissue cells. VI. The fate of injected foreign proteins in the mouse.

Authors:  A H COONS; E H LEDUC; M H KAPLAN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

9.  Localization of antigen in tissue cells; cellular distribution of pneumococcal polysaccharides types II and III in the mouse.

Authors:  M E KAPLAN; A H COONS; H W DEANE
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

10.  Fibronectin-mediated uptake of gelatin-coated latex particles by peritoneal macrophages.

Authors:  P W Gudewicz; J Molnar; M Z Lai; D W Beezhold; G E Siefring; R B Credo; L Lorand
Journal:  J Cell Biol       Date:  1980-11       Impact factor: 10.539

View more
  5 in total

Review 1.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

2.  Fibronectin in chronic inflammation: studies using the rat air pouch model of chronic allergic inflammation.

Authors:  D L Scott; M W Robinson; S Yoshino
Journal:  Br J Exp Pathol       Date:  1985-10

3.  Plasma fibronectin and microvascular damage in essential mixed cryoglobulinaemia.

Authors:  V Toschi; P Renoldi; A Motta; C Cimminiello; G Arpaia; G F Fiorini
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

4.  Fibronectin and immune complexes in rheumatic diseases.

Authors:  K E Herbert; J S Coppock; A M Griffiths; A Williams; M W Robinson; D L Scott
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

5.  Differences between plasma and synovial fluid fibronectin.

Authors:  D L Scott; S D Carter; J S Coppock; M Robinson; K W Walton
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.